Amdocs Stock Price, News & Analysis (NASDAQ:DOX)

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs declared a quarterly dividend on Wednesday, August 7th. Shareholders of record on Monday, September 30th will be paid a dividend of $0.285 per share on Friday, October 25th. This represents a $1.14 dividend on an annualized basis and a yield of 1.73%. The ex-dividend date is Friday, September 27th. View Amdocs' Dividend History.

Amdocs declared that its board has approved a share buyback program on Thursday, November 9th 2017, which permits the company to buyback $800,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to purchase shares of its stock through open market purchases. Shares buyback programs are often a sign that the company's leadership believes its shares are undervalued.

Amdocs Limited (NASDAQ:DOX) released its quarterly earnings data on Wednesday, August, 7th. The technology company reported $1.19 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.08. The technology company earned $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. Amdocs had a net margin of 9.90% and a return on equity of 15.70%. Amdocs's quarterly revenue was up 2.2% on a year-over-year basis. During the same period last year, the business posted $1.03 EPS. View Amdocs' Earnings History.

Amdocs is scheduled to release their next quarterly earnings announcement on Tuesday, November 12th 2019. View Earnings Estimates for Amdocs.

Amdocs will be holding an earnings conference call on Tuesday, November 12th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Amdocs updated its FY 2019 earnings guidance on Wednesday, August, 7th. The company provided EPS guidance of $4.28-4.34 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.28. The company issued revenue guidance of $4.070233088-4.109981458 billion, compared to the consensus revenue estimate of $4.09 billion.

1 brokerages have issued 1-year target prices for Amdocs' shares. Their predictions range from $75.00 to $75.00. On average, they expect Amdocs' share price to reach $75.00 in the next twelve months. This suggests a possible upside of 14.0% from the stock's current price. View Analyst Price Targets for Amdocs.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Amdocs.

News articles about DOX stock have been trending somewhat positive on Monday, InfoTrie Sentiment reports. The research firm ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Amdocs earned a daily sentiment score of 0.8 on InfoTrie's scale. They also gave news coverage about the technology company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term. View News Stories for Amdocs.

Amdocs saw a drop in short interest in the month of September. As of September 30th, there was short interest totalling 2,390,000 shares, a drop of 9.1% from the August 30th total of 2,630,000 shares. Based on an average trading volume of 589,600 shares, the short-interest ratio is presently 4.1 days. Approximately 1.8% of the shares of the company are sold short. View Amdocs' Current Options Chain.

Some companies that are related to Amdocs include Accenture (ACN), IBM (IBM), Cognizant Technology Solutions (CTSH), Gartner (IT), Leidos (LDOS), EPAM Systems (EPAM), Booz Allen Hamilton (BAH), Caci International (CACI), Teradata (TDC), Mantech International (MANT), Virtusa (VRTU), Forrester Research (FORR), The Hackett Group (HCKT), Unisys (UIS) and Servicesource International (SREV).

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include QUALCOMM (QCOM), Home Depot (HD), Activision Blizzard (ATVI), Alphabet (GOOG), Micron Technology (MU), AbbVie (ABBV), Boeing (BA), Caterpillar (CAT), Chevron (CVX) and Enterprise Products Partners (EPD).

Amdocs' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Robeco Institutional Asset Management B.V. (0.99%), Boston Trust Walden Corp (0.19%), Envestnet Asset Management Inc. (0.15%), Denali Advisors LLC (0.07%), Zurcher Kantonalbank Zurich Cantonalbank (0.05%) and State of Alaska Department of Revenue (0.05%).

DOX stock was sold by a variety of institutional investors in the last quarter, including Fox Run Management L.L.C., CenturyLink Investment Management Co, Denali Advisors LLC, Cerebellum GP LLC and Bowling Portfolio Management LLC.

DOX stock was purchased by a variety of institutional investors in the last quarter, including Zurcher Kantonalbank Zurich Cantonalbank , Robeco Institutional Asset Management B.V., Envestnet Asset Management Inc., State of Alaska Department of Revenue, Henry James International Management Inc., Boston Trust Walden Corp, Brinker Capital Inc. and Arden Trust Co.

Shares of DOX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of DOX stock can currently be purchased for approximately $65.81.

Amdocs has a market capitalization of $9.19 billion and generates $3.97 billion in revenue each year. The technology company earns $354.39 million in net income (profit) each year or $3.74 on an earnings per share basis. Amdocs employs 24,381 workers across the globe.View Additional Information About Amdocs.

The official website for Amdocs is http://www.amdocs.com/.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The technology company can be reached via phone at 1 314 212 7000 or via email at [email protected]